Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
Jones Day partner Maureen Bennett talks about how advancements in digital technology and their clinical trial applications have introduced additional regulatory regimes in the United States...
European UnionFood, Drugs, Healthcare, Life Sciences
Jones Day partner Maureen Bennett talks about how advancements
in digital technology and their clinical trial applications have
introduced additional regulatory regimes in the United States and
the European Union, and describes the differences between the U.S.
and EU models. Maureen also discusses the new clinical trial
regulations expected from the U.S. Food and Drug Administration in
the fall of 2020.
Originally published by Jones Day, on June 2020
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
